Please click on the relevant link for the information you require
All content is applicable to NHS South West London and SWL Providers (including Acute Trusts, Mental Health Trust and Community Services providers).
Denosumab (Osvyrti brand only): Shared care for the treatment of osteoporosis in post menopausal women (New September 2026)
New shared care – Denosumab (Osvyrti brand only) for the treatment of osteoporosis post menopausal women within rheumatology service.
Erectile Dysfunction guidelines (Updated August 2026)
Updated Erectile Dysfunction guidelines (adults)
Diabetes blood glucose and ketone meters, testing strips and lancets position statement (Updated June 2026)
Updated position statement for diabetes blood glucose and ketones meters, testing strips and lancets.
Lipid guidelines (Updated May 2026)
The updated lipid guidelines is intended for primary care clinicians working within NHS South West London to support the assessment, initiation and optimisation of lipid lowering therapy in adults for the primary and secondary prevention of cardiovascular disease.
SGLT2 (Sodium glucose co-transporter-2) inhibitors in management of heart failure (Updated April 2026)
The information sheet for SGLT-2 inhibitors in the management of heart failure in adults has been updated.
Guanfacine (adults) shared care (New March 2026)
New shared care- Guanfacine for patients in adults services
Type 2 Diabetes – Liraglutide (Children and Young People) (New Dec 2025)
The information is for prescribers within general practice to support the on-going prescribing of liraglutide for children and young people (CYP) with type 2 diabetes (T2DM).
Bezafibrate shared care (New)
The bezafibrate shared care guidance is for use in patients within hepatology.
Epilepsy (adults) (New)
The Epilepsy (adults) guidance is intended for use by clinicians when using anti-seizure medication (ASM), also called antiepileptic drugs (AEDs).
Midodrine prescribing guidance (New Dec 2025)
The Midodrine prescribing guidance is aimed at primary and secondary care clinicians involved in the management of patients with;
- Inappropriate sinus tachycardia (IST),
- Postural orthostatic tachycardia syndrome (POTS)
- Severe orthostatic hypotension due to autonomic dysfunction.
DOAC (Direct Oral Anticoagulants) FAQs (New Dec 2025)
The DOAC FAQs aims to provide information to assist healthcare professionals in primary care with queries concerning DOACs and advice concerning when a referral and/or further investigation is appropriate for their patient.
Valproate Shared Care (New)
The Valproate shared care guidance is for women of child bearing potential who do not meet all the criteria outlined in the Pregnancy Prevention programme. It is supported by the Valproate Safer Use Policy.
Dizziness: Treatment and Referral Pathways (for adults) in Primary Care (New)
This guidance is aimed at primary care clinicians. It outlines the primary care treatment and referral pathways for the common causes of dizziness in adults (18 years of age and above) in NHS South West London. It is also available as a visual summary flow chart. In addition, the dizziness training webinar delivered across SWL is a useful resource.
